Tagged pulmonary-hypertension
Press Release
Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease
PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world
Read Press Release
Press Release
Vascular BioSciences Awarded $1.2 Million Contract from the NHLBI's VITA Program to Develop CAR Peptide Therapeutic Adjuvant for PAH Targeted Therapy
VBS announced the award of a $1.2 million, milestone-based, 3-year contract from the National Heart Lung Blood Institute (NHLBI) of the National Institutes of Health (NIH) to expedite the development of CAR therapeutic peptide pulmonary hypertension
Read Press Release